Technology & AIAug 19, 2026
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread.
The vaccine reportedly thwarted the cancer's return and spread.
Sign in to learn & save →
The frontier is open to all. Sign in to learn this from first principles and save it to your knowledge base.